Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 3260884)

Published in Crit Care Med on April 01, 2011

Authors

Carolyn S Calfee1, Lorraine B Ware, David V Glidden, Mark D Eisner, Polly E Parsons, B Taylor Thompson, Michael A Matthay, National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network

Author Affiliations

1: Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143-0111, USA. carolyn.calfee@ucsf.edu

Articles citing this

The acute respiratory distress syndrome. J Clin Invest (2012) 5.61

Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med (2013) 2.17

Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 1.72

Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation. Eur Respir J (2012) 1.46

Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care (2013) 1.26

Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol (2012) 1.24

Acute respiratory distress syndrome: A clinical review. Pulm Circ (2011) 1.02

The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J (2013) 0.95

Biomarkers in acute lung injury--marking forward progress. Crit Care Clin (2011) 0.95

Pathophysiology and biomarkers of acute respiratory distress syndrome. J Intensive Care (2014) 0.92

Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Crit Care (2013) 0.89

Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS One (2012) 0.88

Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am J Respir Cell Mol Biol (2012) 0.87

Recent advances in understanding and treating ARDS. F1000Res (2016) 0.87

Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci (2014) 0.87

Improving risk classification of critical illness with biomarkers: a simulation study. J Crit Care (2013) 0.87

Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors. PLoS One (2014) 0.84

Acute respiratory distress syndrome: prevention and early recognition. Ann Intensive Care (2013) 0.81

Biomarkers of acute lung injury: worth their salt? BMC Med (2011) 0.80

Prognostic factors in the acute respiratory distress syndrome. Clin Transl Med (2015) 0.80

Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children. BMC Med Genomics (2012) 0.79

Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome. Crit Care Med (2013) 0.79

Analysis of time-resolved gene expression measurements across individuals. PLoS One (2013) 0.76

Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS. Front Pediatr (2016) 0.75

Biology and pathology of fibroproliferation following the acute respiratory distress syndrome. Intensive Care Med (2014) 0.75

A new prediction score for critically ill patients-do we need an Apgar score for acute respiratory distress syndrome? J Thorac Dis (2017) 0.75

Incorporating Inflammation into Mortality Risk in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med (2017) 0.75

Current Concepts of ARDS: A Narrative Review. Int J Mol Sci (2016) 0.75

Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial. Ann Intensive Care (2016) 0.75

MortalityPredictors.org: a manually-curated database of published biomarkers of human all-cause mortality. Aging (Albany NY) (2017) 0.75

Articles cited by this

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03

Incidence and outcomes of acute lung injury. N Engl J Med (2005) 21.56

Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation (2007) 20.44

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest (1991) 16.06

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med (2008) 7.33

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med (2005) 5.76

Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med (2009) 3.86

Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med (1983) 3.79

Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med (2007) 3.31

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax (2008) 3.13

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med (2007) 2.79

Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med (2006) 2.61

Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med (2004) 2.49

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax (2003) 2.47

Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med (1995) 2.43

Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28

Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med (2004) 2.18

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest (2009) 2.17

Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol (2004) 2.15

Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med (2008) 2.09

Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med (2005) 1.73

Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med (2008) 1.61

Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med (2007) 1.59

Variation in ICU risk-adjusted mortality: impact of methods of assessment and potential confounders. Chest (2008) 1.58

Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest (2007) 1.32

Higher urine desmosine levels are associated with mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.18

Technology Insight: biomarker development in acute kidney injury--what can we anticipate? Nat Clin Pract Nephrol (2008) 1.15

Articles by these authors

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

Acute respiratory distress syndrome: the Berlin Definition. JAMA (2012) 21.04

Comparison of two fluid-management strategies in acute lung injury. N Engl J Med (2006) 19.54

Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40

Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med (2004) 11.78

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med (2006) 9.52

Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med (2012) 9.19

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33

Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07

Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med (2006) 7.97

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med (2012) 6.29

Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med (2002) 6.17

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med (2005) 5.76

Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA (2008) 5.68

Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol (2007) 5.66

The acute respiratory distress syndrome. J Clin Invest (2012) 5.61

Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27

Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med (2011) 5.24

Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med (2005) 5.16

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA (2011) 5.08

Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA (2012) 4.67

An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol (2011) 4.65

The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (2011) 4.57

Abnormal brain development in newborns with congenital heart disease. N Engl J Med (2007) 4.55

Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med (2008) 4.21

Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr (2010) 4.20

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92

Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med (2009) 3.86

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A (2009) 3.84

Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med (2003) 3.74

Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg (2007) 3.49

The role of open-lung biopsy in ARDS. Chest (2004) 3.46

Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med (2014) 3.39

Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2013) 3.38

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med (2006) 3.38

Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med (2007) 3.31

Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med (2013) 3.30

Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med (2008) 3.28

Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA (2005) 3.21

The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 3.18

Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12

Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest (2009) 3.08

Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A (2010) 3.05

Nonventilatory treatments for acute lung injury and ARDS. Chest (2007) 3.02

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2003) 3.02

Postobstructive pulmonary edema: a case for hydrostatic mechanisms. Chest (2007) 2.97

Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary. Crit Care Med (2004) 2.95

Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev (2003) 2.95

Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med (2012) 2.92

COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest (2005) 2.88

Patterns of brain injury in term neonatal encephalopathy. J Pediatr (2005) 2.86

Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2015) 2.80

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med (2007) 2.79

Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol (2009) 2.77

Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients. Crit Care Med (2015) 2.77

The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med (2012) 2.72

Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells (2010) 2.72

Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med (2005) 2.67

Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med (2004) 2.66

Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med (2013) 2.66

Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation (2006) 2.65

Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med (2006) 2.63

Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med (2003) 2.63

Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr (2005) 2.63

Clinical practice. Acute pulmonary edema. N Engl J Med (2005) 2.62

Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. Am J Respir Crit Care Med (2006) 2.61

Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest (2007) 2.58

Transfusion-related acute lung injury: a review. Chest (2004) 2.56

Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med (2011) 2.55

Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med (2009) 2.52

Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med (2004) 2.51

Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest (2006) 2.50